Literature DB >> 18370346

Second assessment of NeuroAIDS in Africa.

Kevin Robertson1, Kathy Kopnisky, James Hakim, Concepta Merry, Noeline Nakasujja, Colin Hall, Moussa Traore, Ned Sacktor, David Clifford, Charles Newton, Annelies Van Rie, Penny Holding, Janice Clements, Christine Zink, Jens Mielk, Mina Hosseinipour, Umesh Lalloo, Farida AMod, Christina Marra, Scott Evans, Jeff Liner.   

Abstract

In July of 2006, the National Institute of Mental Health (NIMH) Center for Mental Health Research on AIDS (CMHRA) sponsored the second conference on the Assessment of NeuroAIDS in Africa, which was held in Arusha, Tanzania. The conference mission was to address the regional variations in epidemiology of HIV-related neurological disorders as well as the assessment and diagnosis of these disorders. Participants discussed and presented data regarding the relevance and translation of neuroAIDS assessment measures developed in resource intensive settings and the challenges of neuro-assessment in Africa, including the applicability of current tools, higher prevalence of confounding diseases, and the complexity of diverse cultural settings. The conference presentations summarized here highlight the need for further research on neuroAIDS in Africa and methods for assessing HIV-related neurological disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18370346      PMCID: PMC2755561          DOI: 10.1080/13550280701829793

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  55 in total

1.  Transmission routes of HIV-1 gp120 from brain to lymphoid tissues.

Authors:  M F Cashion; W A Banks; K L Bost; A J Kastin
Journal:  Brain Res       Date:  1999-03-20       Impact factor: 3.252

2.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

Authors:  J J Sevigny; S M Albert; M P McDermott; J C McArthur; N Sacktor; K Conant; G Schifitto; O A Selnes; Y Stern; D R McClernon; D Palumbo; K Kieburtz; G Riggs; B Cohen; L G Epstein; K Marder
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

3.  Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.

Authors:  Manisha C Shanbhag; Richard M Rutstein; Theoklis Zaoutis; Huaqing Zhao; David Chao; Jerilynn Radcliffe
Journal:  Arch Pediatr Adolesc Med       Date:  2005-07

4.  Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?

Authors:  Alexander Imhof; Bruno Ledergerber; Huldrych F Günthard; Stefan Haupts; Rainer Weber
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

5.  Long-term effect of acetyl-L-carnitine for antiretroviral toxic neuropathy.

Authors:  Christian Herzmann; Margaret A Johnson; Mike Youle
Journal:  HIV Clin Trials       Date:  2005 Nov-Dec

6.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Authors:  E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

7.  Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.

Authors:  V Tozzi; P Balestra; S Galgani; P Narciso; F Ferri; G Sebastiani; C D'Amato; C Affricano; F Pigorini; F M Pau; A De Felici; A Benedetto
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

8.  Human immunodeficiency virus type 1 subtypes differ in disease progression.

Authors:  P J Kanki; D J Hamel; J L Sankalé; C c Hsieh; I Thior; F Barin; S A Woodcock; A Guèye-Ndiaye; E Zhang; M Montano; T Siby; R Marlink; I NDoye; M E Essex; S MBoup
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

9.  Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study.

Authors:  Maurizio Osio; Francesco Muscia; Luisa Zampini; Caterina Nascimbene; Enrico Mailland; Antonietta Cargnel; Claudio Mariani
Journal:  J Peripher Nerv Syst       Date:  2006-03       Impact factor: 3.494

10.  Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.

Authors:  Ashwin Vasan; Boris Renjifo; Ellen Hertzmark; Beth Chaplin; Gernard Msamanga; Max Essex; Wafaie Fawzi; David Hunter
Journal:  Clin Infect Dis       Date:  2006-02-09       Impact factor: 9.079

View more
  5 in total

1.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

2.  Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya.

Authors:  Deanna Cettomai; Judith Kwasa; Gretchen L Birbeck; Richard W Price; Elizabeth A Bukusi; Ana-Claire Meyer
Journal:  J Neurol Sci       Date:  2011-06-11       Impact factor: 3.181

3.  Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.

Authors:  A K Njamnshi; A C Zoung-Kanyi Bissek; P Ongolo-Zogo; E N Tabah; A Z Lekoubou; F N Yepnjio; J Y Fonsah; C T Kuate; S A Angwafor; F Dema; D M Njamnshi; C Kouanfack; V de P Djientcheu; W F T Muna; G D Kanmogne
Journal:  J Neurol Sci       Date:  2009-07-24       Impact factor: 3.181

4.  Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.

Authors:  Wuze Ren; Alexandra Mumbauer; Agegnehu Gettie; Michael S Seaman; Kasi Russell-Lodrigue; James Blanchard; Susan Westmoreland; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

Review 5.  Neurological disorders in HIV in Africa: a review.

Authors:  William P Howlett
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.